[HTML][HTML] Phosphoproteomics in cancer

HC Harsha, A Pandey - Molecular oncology, 2010 - Elsevier
Reversible protein phosphorylation serves as a basis for regulating a number of cellular
processes. Aberrant activation of kinase signaling pathways is commonly associated with …

Technological advances for interrogating the human kinome

A Baharani, B Trost, A Kusalik… - Biochemical Society …, 2017 - portlandpress.com
There is increasing appreciation among researchers and clinicians of the value of
investigating biology and pathobiology at the level of cellular kinase (kinome) activity …

[HTML][HTML] HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer

M Gijsen, P King, T Perera, PJ Parker, AL Harris… - PLoS …, 2010 - journals.plos.org
Herceptin (trastuzumab) is used in patients with breast cancer who have HER2 (ErbB2)–
positive tumours. However, its mechanisms of action and how acquired resistance to …

The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation

I Vivanco, D Rohle, M Versele… - Proceedings of the …, 2010 - National Acad Sciences
The phosphatase and tensin homolog (PTEN) is a tumor suppressor that is inactivated in
many human cancers. PTEN loss has been associated with resistance to inhibitors of the …

Profiling activity of cellular kinases in migrating T-cells

CS Chirumamilla, MHUT Fazil, C Perez-Novo… - T-Cell Motility: Methods …, 2019 - Springer
T-Lymphocyte kinases are important checkpoints that control T-cell motility by regulating a
diverse range of signal transduction pathways. The distinct configuration of kinase events in …

Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non–small cell lung cancer

I Kawada, R Hasina, Q Arif, J Mueller, E Smithberger… - Cancer research, 2014 - AACR
Lung cancer is a heterogeneous disease encompassing a wide array of genetic
abnormalities. The MET receptor tyrosine kinase is altered in many lung cancers, especially …

[HTML][HTML] Protein kinase activity decreases with higher Braak stages of Alzheimer's disease pathology

AFN Rosenberger, R Hilhorst, E Coart… - Journal of …, 2016 - content.iospress.com
Alzheimer's disease (AD) is characterized by a long pre-clinical phase (20–30 years), during
which significant brain pathology manifests itself. Disease mechanisms associated with …

Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling

S Folkvord, K Flatmark, S Dueland, R De Wijn… - International Journal of …, 2010 - Elsevier
PURPOSE: Tumor response of rectal cancer to preoperative chemoradiotherapy (CRT)
varies considerably. In experimental tumor models and clinical radiotherapy, activity of …

Peptide microarrays for profiling of serine/threonine kinase activity of recombinant kinases and lysates of cells and tissue samples

R Hilhorst, L Houkes, M Mommersteeg, J Musch… - … : Methods and Protocols, 2013 - Springer
Peptide microarray technology can be used to identify substrates for recombinant kinases, to
measure kinase activity and changes thereof in cell lysates and lysates from fresh frozen …

[HTML][HTML] High throughput kinomic profiling of human clear cell renal cell carcinoma identifies kinase activity dependent molecular subtypes

JC Anderson, CD Willey, A Mehta, K Welaya, D Chen… - PloS one, 2015 - journals.plos.org
Despite the widespread use of kinase-targeted agents in clear cell renal cell carcinoma (CC-
RCC), comprehensive kinase activity evaluation (kinomic profiling) of these tumors is …